Ya-Ting Hsu

13PUBLICATIONS
49CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 08, 2026
Peripheral T-Cell Lymphomas in Southern Taiwan: Epidemiology, Treatment Patterns, and Long-Term Outcomes.

|Apr 22, 2026
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study.

|Jan 13, 2026
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study.

Marta Peña, Giulia Losi, Víctor Navarro

|Feb 02, 2024
Glofitamab as a salvage treatment for B-cell lymphomas in the real world: A multicenter study in Taiwan.

Ya-Ting Hsu, Shang-Ju Wu, Hsiao-Wen Kao

|May 11, 2023
Multiple myeloma presenting with hepatic light chain deposition.

Li-Chang Chang, Ya-Ting Hsu

|Feb 27, 2023
Electrical Sympathetic Neuromodulation Protects Bone Marrow Niche and Drives Hematopoietic Regeneration during Chemotherapy.

Ya-Ting Hsu, Li-Hsien Chen, Ya-Hui Liu

Pageof 3

Frequent Collaborators

3 joint publications

Tsai-Yun Chen

2 joint publications

Li-Chang Chang

1 joint publications

Sin-Syue Li

1 joint publications

Kung-Chao Chang